I feel like someone who has just run a marathon: the multiple appointments for wedding-related matters alone kept me occupied for weeks. That included organizing and hosting a bridal shower, planning a wedding rehearsal dinner, overseeing hotel arrangements for out-of-town guests, organizing logistics for limos, etc. Then — with less than 3 weeks before W-Day — my Dad slid off a chair and broke his hip. Suddenly the wedding prep was supplemented by multiple trips (5 hours by train) to help my elderly parents faced with a crisis, phone calls with my siblings and conversations with medical personnel. Continue reading
Terry Roycroft, president and CEO of Medicinal Cannabis Resource Centre Inc. (MCRCI), was at the 21st Annual Rural and Remote Medicine Course “Sea To Sea To Sea” to raise awareness amongst physicians. In this video, he tells ABN about the many reasons he was there, including:
- To spread information about medicinal cannabis.
- To explain how Health Canada’s medicinal cannabis program works.
- To talk about pain management for arthritis.
- To inform physicians about a clinical trial for a topical pain treatment.
To learn more about this event, please click here.
To view more interviews, please click here.
A small pleasure when spending time in Southwest Florida during the winter is to attend the wide variety of arts and crafts shows staged by local artists’ associations and charitable organizations. Held during the winter “season”, these outdoor exhibitions feature everything from high-quality fine art and jewelry to inexpensive pottery and hobby crafts. Many of the artisans travel around on a show circuit from city to city, so there is a certain repetition in the type of items for sale. Continue reading
Total hip replacement, also known as total hip arthroplasty (THA), is more often performed in women than men. Sex-specific risk factors and outcomes have been investigated in other major surgical procedures and, in theory, might be more important to study in THA because of anatomical differences between men and women, the authors write in the study background.
Researchers noted this was true even after taking other individual risk factors into account. They said their findings could help doctors better manage the differences between men and women.
Read more: CBC News, February 2013
Imagine being able to get rid the pain of osteoporosis or rheumatoid arthritis (RA) for months with a single injection. That may soon become a reality. A new medication, which is just about to enter its first human trials, looks promising.
Read more: Jo Willey, Daily Express, February 2013
To try to reduce prescription drug abuse, last week an advisory panel to the U.S. Food and Drug Administration (FDA) voted to recommend toughening the restrictions on painkillers like Vicodin that contain hydrocodone.
If the recommendation is adopted by the FDA, the medication which is now classified as a Schedule III drug, will be placed in the same category as oxycodone, morphine, and methadone that have high abuse potential (Schedule II).
What does this all mean?
Well, if the FDA approves the change, patients would not be able to get as many hydrocodone pills as they used to and refills would be limited. This is a cause for concern for pain patient advocacy groups who worry that patients may have trouble getting access to medications they need.
Read the full story here: Stephanie Smith, CNN, January 2013